Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inotuzumab Ozogamicin”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Large-scale testing (Phase 3)Ended earlyNCT01232556
What this trial is testing

Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

Who this might be right for
Lymphoma, Non-Hodgkin
Pfizer 338
Testing effectiveness (Phase 2)Looking for participantsNCT01371630
What this trial is testing

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBurkitt-Like Lymphoma With 11q Aberration+6 more
M.D. Anderson Cancer Center 276
Testing effectiveness (Phase 2)Study completedNCT00868608
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma

Who this might be right for
Lymphoma
Pfizer 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT05456698
What this trial is testing

Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy

Who this might be right for
Acute Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 31
Post-approval studies (Phase 4)Study completedNCT03677596
What this trial is testing

Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

Who this might be right for
LeukemiaPrecursor b-Cell Lymphoblastic Leukemia-LymphomaACUTE LYMPHOBLASTIC LEUKEMIA
Pfizer 102
Large-scale testing (Phase 3)Study completedNCT01564784
What this trial is testing

Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Pfizer 326
Post-approval studies (Phase 4)Study completedNCT05687032
What this trial is testing

Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Pfizer 44
Not applicableStudy completedNCT05597085
What this trial is testing

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

Who this might be right for
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Pfizer 32
Testing effectiveness (Phase 2)Looking for participantsNCT03739814
What this trial is testing

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Ended earlyNCT03913559
What this trial is testing

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital 5
Testing effectiveness (Phase 2)Study completedNCT02311998
What this trial is testing

Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML

Who this might be right for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBlasts More Than 5 Percent of Bone Marrow Nucleated Cells+4 more
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Looking for participantsNCT03104491
What this trial is testing

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Leland Metheny 44
Early research (Phase 1)Looking for participantsNCT06863259
What this trial is testing

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Children's Hospital Medical Center, Cincinnati 28
Testing effectiveness (Phase 2)Study completedNCT01664910
What this trial is testing

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT01363297
What this trial is testing

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Pfizer 72
Testing effectiveness (Phase 2)UnknownNCT03610438
What this trial is testing

Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 76
Large-scale testing (Phase 3)Looking for participantsNCT04307576
What this trial is testing

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Who this might be right for
Leukemia, Acute Lymphoblastic
Mats Heyman 6,430
Testing effectiveness (Phase 2)Looking for participantsNCT06554626
What this trial is testing

Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05748171
What this trial is testing

Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Who this might be right for
ACUTE LYMPHOBLASTIC LEUKEMIA
Pfizer 100
Not applicableLooking for participantsNCT06025682
What this trial is testing

Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO

Who this might be right for
Acute Lymphoblastic LeukemiaInfectionsBacterial Infections+4 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 158
Load More Results